Qualigen Therapeutics Announces 1-for-50 Reverse Stock Split
Company Announcements

Qualigen Therapeutics Announces 1-for-50 Reverse Stock Split

Qualigen Therapeutics ( (QLGN) ) has issued an update.

Qualigen Therapeutics is executing a 1-for-50 reverse stock split to boost its stock price and meet Nasdaq’s listing requirements, effective November 5, 2024. This move will consolidate every 50 shares into one, reducing outstanding shares from 36.7 million to around 737,000, while maintaining the number of authorized shares. Investors holding fractional shares will receive cash compensation.

Find detailed analytics on QLGN stock on TipRanks’ Stock Analysis page.

Related Articles
TheFlyQualigen Therapeutics to implement 1-for-50 reverse stock split
TheFlyQualigen Therapeutics files to sell 14M shares of common stock
Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App